Disposable Injection Pen For Recombinant Human Follicle-stimulating Hormone Fc Fusion Protein For Injection
New Products From This Supplier
3 ml plastic growth hormone/insulin pen syringe product type: non-reusable.
* materials:/ABS/PC/POM
* usage: diabetic (insulin) , HGH (human growth hormone) , ghrelin, interferon, Glp-1 injection.
* Safety Standard: GB/T 32610. * dose accuracy error: & Lt. 5% , according to ISO 11608-1.
* compatible PIN type: compatible with standard pins, ISO 11608-2.
* main container: standard 3 ML cartridge, ISO 11608-3 compliant.
*Fields of application: various water medicine injections, such as insulin, Glp-1, bamboo, saccharin, Lylaru peptide, and other peptide drugs.
* good feel/workmanship.
* connection: Fastener Connection, installation speed is faster.
* precision range: stable injection process, precision error control in 2% -4% (international standard 5%) .
* Injection Range: 0.60 IU, 1 IU in increments, with a maximum of 60 IU (0.6 ml) .
* injection resistance: less than 25N.
* surface: Matte/paint/plating.
* logo: surface can be laser engraved.
* life expectancy: 3 years or 3,000 times.
*Personal: customizable appearance to improve thrust and accuracy.
Needle: compatible with various insulin needles on the market.
Business Nature
Manufacturer
No. Employees
100
Year Established
2002
Country/Region
Changzhou, China
Main Products
Insulin Injection Pen...
Payment Terms
Cash, MoneyGram, Doc Against Acceptance (D/A), Doc Against Payment (D/P), Letter of Credit (L/C), Bank wire (T/T)
Oukai is headquartered in Changzhou, Jiangsu. Its main industries are electrical machinery and medical equipment, and there are about 600 employees in total. 2021/2022 annual turnover: 500-600 million yuan (about 80 million US dollars) Oukai is a leading independent medical technology company in the field of self-injection, with over 7 years of management experience in developing and manufacturing injector pens and automatic injectors, ideal partner for pharmaceutical and biopharmaceutical companie.
